• Vector BioPharma AG

    BS
    active
    Check credit rating Timeline
    Check credit ratingCredit rating
    Register number: CH-270.3.016.315-0
    Sector: Research and development

    Age of the company

    2 years

    Turnover in CHF

    PremiumPremium

    Capital in CHF

    400'000

    Employees

    PremiumPremium

    Active brands

    5

    Reports for Vector BioPharma AG

    preview

    Credit rating information

    Evaluation of credit rating with traffic light as risk indicator and other helpful data about the company. Find out more
    preview

    Economic information

    Comprehensive information about the economic situation of a company. Find out more
    preview

    Payment behaviour

    Assessment of the payment behaviour based on past invoices. Find out more
    preview

    Payment collection information

    Overview of current and past debt enforcement proceedings. Find out more

    Company dossier as PDF

    Contact information, changes in the company, turnover and employee figures, management, ownership, shareholding structure and other company data.
    Retrieve company dossier

    About Vector BioPharma AG

    • Vector BioPharma AG has its legal headquarters in Basel and is active. It operates in the sector «Research and development».
    • The company was founded on 22.06.2021.
    • On the 01.03.2024 the commercial register entry of the company was last changed. Under «Notifications» you will find all changes.
    • The company Vector BioPharma AG is registered under the UID CHE-471.427.733.
    • 5 various trademarks or applications have been registered by the company Vector BioPharma AG in the IPI.
    • Next to the company Vector BioPharma AG there are 30 other active companies with an identical address. These include: AlpENa Biosciences AG, Basel Tourismus, Boutique Danoise AG.

    Commercial register information

    Source: SOGC

    Sector

    Research and development

    Purpose (Original language) Customise the company purpose with just a few clicks.

    Die Gesellschaft bezweckt die Erforschung, die Entwicklung, die Herstellung, die Verwertung, den Erwerb und den Vertrieb von pharmazeutischen und diagnostischen Produkten und Technologien. Die Gesellschaft kann alle kommerziellen, vertraglichen und finanziellen Geschäfte eingehen, die geeignet sind, den Zweck der Gesellschaft zu fördern, oder die direkt oder indirekt damit in Zusammenhang stehen. Ferner kann sie Zweigniederlassungen im In- und Ausland einrichten und sich an anderen Unternehmungen beteiligen oder sich mit diesen zusammenschliessen. Die Gesellschaft kann Grundstücke erwerben, halten und veräussern.

    Auditor

    Source: SOGC

    Current auditor (1)
    Name City Since Until
    Ernst & Young AG
    Basel 25.06.2021

    Would you like to adjust the auditors? Click here.

    Other company names

    Source: SOGC

    Past and translated company names

    • Vector BioPharma SA
    • Vector BioPharma Ltd
    Would you like to update the company name? Click here.

    Ownership structure

    No information on the ownership structure is known to us.

    Holdings

    No information on holdings is known to us.

    Trademarks

    Source: Swissreg
    Trademark Registration date Status Number
    SHREAD 23.02.2023 active 02434/2023
    VECTOR BIOPHARMA 19.05.2022 active 01235/2022

    Newest SOGC notifications: Vector BioPharma AG

    The latest updates from the Swiss Official Gazette of Commerce (SOGC) are available in the original language of the source commercial register office only. View all notifications

    SOGC 240301/2024 - 01.03.2024
    Categories: Change in management

    Publication number: HR02-1005975034, Commercial Registry Office Basel-Stadt, (270)

    Vector BioPharma AG, in Basel, CHE-471.427.733, Aktiengesellschaft (SHAB Nr. 175 vom 11.09.2023, Publ. 1005835114).

    Ausgeschiedene Personen und erloschene Unterschriften:
    Seiler, Nadine Stephanie, von Tägerig, in Münchenstein, mit Kollektivunterschrift zu zweien;
    Smith, Sheena Nichole, amerikanische Staatsangehörige, in Bubendorf, mit Kollektivunterschrift zu zweien.

    SOGC 230911/2023 - 11.09.2023
    Categories: Change in management

    Publication number: HR02-1005835114, Commercial Registry Office Basel-Stadt, (270)

    Vector BioPharma AG, in Basel, CHE-471.427.733, Aktiengesellschaft (SHAB Nr. 162 vom 23.08.2023, Publ. 1005822045).

    Ausgeschiedene Personen und erloschene Unterschriften:
    Barbet, Nicholas Charles, britischer Staatsangehöriger, in Buckten, mit Kollektivunterschrift zu zweien;
    Mayr, Lorenz, deutscher Staatsangehöriger, in Binzen (DE), mit Kollektivunterschrift zu zweien.

    SOGC 230823/2023 - 23.08.2023
    Categories: Change in management

    Publication number: HR02-1005822045, Commercial Registry Office Basel-Stadt, (270)

    Vector BioPharma AG, in Basel, CHE-471.427.733, Aktiengesellschaft (SHAB Nr. 100 vom 25.05.2023, Publ. 1005753801).

    Eingetragene Personen neu oder mutierend:
    Seiler, Nadine Stephanie, von Tägerig, in Münchenstein, mit Kollektivunterschrift zu zweien.

    Hit list

    Here you will find a link from the management to a hit list of persons with the same name who are registered in the commercial register.

    Title
    Confirm